Elixinol Wellness

Elixinol Wellness EBITDA per Share

The EBITDA per Share of Elixinol Wellness (EXL.AX) as of Oct 17, 2026 is -0.02 AUD. In the previous year, EBITDA per Share was -0.02 AUD — a change of -19.96% (higher).

EBITDA per Share

-0.02AUD

YoY

-19.96%

Last updated:

EBITDA per Share of Elixinol Wellness is 2025 -0.02 AUD. EBITDA per Share of Elixinol Wellness was 2024 -0.02 AUD. It decreases by -19.96% higher compared to the previous year.

The Elixinol Wellness EBITDA per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Share
Date
EBITDA per Share
Jan 1, 2018
-0.00 AUD
Jan 1, 2019
-0.11 AUD
Jan 1, 2020
-0.05 AUD
Jan 1, 2021
-0.04 AUD
Jan 1, 2022
-0.02 AUD
Jan 1, 2023
-0.01 AUD
Jan 1, 2024
-0.02 AUD
Jan 1, 2025
-0.02 AUD
The Elixinol Wellness EBITDA per Share history
YEAREBITDA per ShareYoY
-0.02AUD-19.96%
-0.02AUD+203.19%
-0.01AUD-70.24%
-0.02AUD-37.00%
-0.04AUD-30.31%
-0.05AUD-51.08%
-0.11AUD+11,066.59%
-0.00AUD-95.14%
-0.02AUD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Elixinol Wellness Stock analysis

What does Elixinol Wellness do? Elixinol Wellness Ltd, trading under the ticker symbol EXL.AX and identified by the ISIN AU000000EXL4, is a Sydney-based entity operating within the Consumer Staples sector, specifically in the consumer products industry. The company officially entered the public markets through an initial public offering on January 8, 2018. Its primary business activity involves the sale of nutraceutical and related hemp products, positioning itself as a significant player in the global hemp-derived wellness market. The corporate headquarters are located in Sydney, New South Wales, serving as the central hub for its international operations and strategic direction. The firm’s commercial activities are broadly categorized into marketing and selling hemp-derived nutraceutical, cosmetic, and food products under two core brands: Elixinol and Hemp Foods Australia. The company’s operational footprint is extensive, covering various key markets across the globe. In the Americas, the company operates through a presence in Colorado, United States, where it markets and sells Elixinol branded hemp and other plant-derived nutraceutical and skincare products. This North American segment represents a crucial part of its consumer-facing strategy. In Australia, the company’s operations include Hemp Foods Australia, which functions as a wholesaler, retailer, manufacturer, and exporter of both bulk and branded raw materials as well as finished products. This dual-brand approach allows the company to cater to different segments of the market, from raw material supply to direct consumer goods. Internationally, the Elixinol brand is distributed through a network of distribution and trademark licensing agreements. This model is utilized in markets including the United Kingdom, South Africa, Japan, Brazil, and Mexico, with approvals pending for Malaysia. These licensing and distribution arrangements enable the company to expand its reach without necessarily establishing direct operational subsidiaries in every jurisdiction. Additionally, the company serves the Rest of World market by distributing Elixinol branded hemp-derived products through various distributors. This multi-faceted approach to global distribution allows Elixinol Wellness Ltd to leverage local partnerships while maintaining brand consistency. The company’s website, https://www.elixinolwellness.com/site/content/, serves as a central point for information regarding its products and corporate updates. By combining direct operations in key markets with licensing and distribution agreements elsewhere, Elixinol Wellness Ltd aims to capitalize on the growing demand for hemp-based wellness solutions across diverse geographical regions. Elixinol Wellness is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Elixinol Wellness stock

EBITDA per Share of Elixinol Wellness is -0.02 AUD in 2025.

EBITDA per Share of Elixinol Wellness changed from -0.02 AUD to -0.02 AUD, representing a -19.96% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Share Elixinol Wellness since 2006 – with annual values, charts, and detailed analysis.

EBITDA per share divides EBITDA by shares outstanding, showing the operating cash earnings allocated to each share before depreciation and financing effects.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Elixinol Wellness

All Key Metrics — Elixinol Wellness